Temsirolimus

FDA Approved: * July 30, 2018
Pharm Company: * ACCORD HLTHCARE
Category: Cancer

Temsirolimus, sold under the brand name Torisel, is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in May 2007,[3] and was also approved by the European Medicines Agency (EMA) in November 2007.[1] It is a derivative and prodrug of sirolimus. Contents 1 Mechanism of action 2 Efficacy 3 Adverse reactions 4 Lung toxicity 5 Dosing 6 See also 7 Refe... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Temsirolimus Kit
NDC: 16729-223
Labeler:
Accord Healthcare Inc.
TemsirolimusTemsirolimus Intravenous Kit
NDC: 65219-200
Labeler:
Fresenius Kabi USA, LLC
TemsirolimusTemsirolimus Kit
NDC: 68083-202
Labeler:
Gland Pharma Limited

Related Brands

Drugs with the same active ingredients

Popular Topics